in type 2 diabetes: a patient -centered approach: position statement of the
American Diabetes Association (ADA) and the European Association for the
Study of Diabetes (EASD) [published correction appears in Diabetes Care.
2013;36(2):490]. Diabetes Care. 2012;35(6):1364-79
54. S
alpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and
nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2010;(4):CD002967
55. P
owers AC, D’Alessio D. Endocrine pancreas and pharmacotherapy of
diabetes mellitus and hypoglycemia. In: Brunton LL, Chabner BA,
Knollmann BC, eds. Good man & Gilman’s Pharmacological Basis of
Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011
56. L
ewis JD, Ferrara A, Peng T, et al. Risk of bladder cancer among diabetic
patients treated with pioglitazone: interim report of a longitudinal cohort